| 328 | 0 | 197 |
| 下载次数 | 被引频次 | 阅读次数 |
蛋白质生物标志物作为疾病分子诊断的重要依据，对早期诊断、疾病分期及治疗效果评估具有重要价值。文章综述了蛋白质生物标志物超灵敏检测技术的研究进展，介绍了常见的蛋白质生物标志物的超灵敏检测技术，特别探讨了基于分子印迹聚合物和纳米技术构建的生物传感器在蛋白质生物标志物超灵敏检测中的应用，这些传感器在检测蛋白质生物标志物方面展现出了高灵敏度和高特异性。此外，文章还讨论了蛋白质生物标志物超灵敏检测面临的挑战，并对未来的发展方向进行了展望。
Abstract：This article reviews the research progress of ultrasensitive detection techniques for protein biomarkers.Protein biomarkers, serving as important evidence for molecular diagnosis of diseases, are of great value for early diagnosis, disease staging, and evaluation of treatment efficacy. The article introduces common ultrasensitive detection techniques for protein biomarkers, with a particular focus on the application of biosensors constructed based on molecularly imprinted polymers and nanotechnology in the ultrasensitive detection of protein biomarkers. These sensors have demonstrated high sensitivity and specificity in detecting protein biomarkers. In addition, the article also discusses the challenges faced in the ultrasensitive detection of protein biomarkers and looks ahead to the future development directions.
1 Levin A,Stevens P E.Early detection of CKD:The benefits,limitations an deffects on prognosis[J].Nature Reviews Nephrology,2011,7(8):446-457.
2 Chen W,Zheng R,Zeng H,et al.Epidemiology of lung cancer in C hina[J].Thoracic Cancer,2015,6(2):209-215.
3 Barta J A,Powell C A,Wisnivesky J P.Global epidemiology of lung cancer[J].Annals of Global Health,2019,85(1):8.
4 Subramanian J,Govindan R.Lung cancer in never smokers:A review[J].Journal of Clinical Oncology,2007,25(5):561-570.
5 Blackhall F V T,Devita S,Hellman S A.Rosenberg (Eds.),cancer:Principles and practice of oncology,seventh edition[J].Surgical Oncology,2006,14(4):195.
6 Honig L S,Vellas B,Woodward M,et al.Trial of solanezumab for mild dementia due to Alzheimer’s disease[J].New England Journal of Medicine,2018,378 (4):321-330.
7 None.The need for early detection and treatment in Alzheimer’s disease[J].EBio Medicine,2016,9:1-2.
8 Maliszewska-Cyna E,Lynch M,Jordan O J,et al.The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer’s disease[J].Current Alzheimer Research,2017,14(1):47-60.
9 Richardet E,Villavicencio R,Hernandez P A,et al.P1.09:Delays in the diagnosis and treatment of lung cancer[J].Journal of Thoracic Oncology,2016,11(10):S185.
10 Ghosh R K,Pandey T,Dey P.Liquid biopsy:A new avenue in pathology[J].Cytopathology,2019,30 (2):138-143.
11 Petsko G A,Ringe D.Protein structure and function[M].Washington:New Science Press,2004.
12 Hanash S.Disease proteomics[J].Nature,2003,422(6928):226-232.
13 Drabovich A P,Martínez-Morillo E,Diamandis E P.Toward an integrated pipeline for protein biomarker development[J].Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics,2015,1854(6):677-686.
14 Waikar S S,Betensky R A,Emerson S C,et al.Imperfect gold standards for kidney injury biomarker evaluation[J].Journal of the American Society of Nephrology,2012,23(1):13-21.
15 Engvall E,Perlmann P.Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G[J].Immunochemistry,1971,8(9):871-874.
16 Yalow R S,Berson S A.Immunoassay of endogenous plasma insulin in man[J].Journal of Clinical Investigation,1960,39(6):1157-1175.
17 Luppa P B,Sokoll L J,Chan D W.Immunosensors:Principles and applications to clinical chemistry[J].Clinica chimica acta,2001,314(1/2):1-26.
18 Aebersold R,Mann M.Mass spectrometry-based proteomics[J].Nature,2003,422(6928):198-207.
19 Bange A,Halsall H B,Heineman W R.Microfluidic immunosensor systems[J].Biosensors and Bioelectronics,2005,20(12):2488-2503.
20 Templin M F,Stoll D,Schrenk M,et al.Protein microarray technology[J].TRENDS in Biotechnology,2002,20(4):160-166.
21 Yang X,Tang Y,Alt R R,et al.Emerging techniques for ultrasensitive protein analysis[J].The Analyst,2016,141(12):3473-3481.
22 Hu R,Sou K,Takeoka S.A rapid and highly sensitive biomarker detection platform based on a temperatureresponsive liposome-linked immunosorbent assay[J].Scientific Reports,2020,10(1):18086.
23 Cardozo K H M,Lebkuchen A,Okai G G,et al.Establishing a mass spectrometry-based system for rapid detection of SARS-Co V-2 in large clinical sample cohorts[J].Nature Communications,2020,11(1):6201.
24 Higashi S,Yagyu K,Nagase H,et al.Ultra-high-speed western blot with the aid of immunoreaction enhancing technology[J].Journal of visualized experiments:Jo VE,2020(163):e61657.
25 Naylor S.Biomarkers:Current perspectives and future prospects[J].Expert Review of Molecular Diagnostics,2003,3(5):525-529.
26 Mayeux R.Biomarkers:Potential uses and limitations[J].Neuro Rx,2004,1:182-188.
27 Gunn G R,Evans C,Yang E.Immunogenicity and biomarkers:Bioanalytical challenges and considerations[J].Bioanalysis,2017,9(22):1729-1732.
28 Yang S Y,Chiu M J,Chen T F,et al.Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases[J].Scientific Reports,2017,7(1):9304.
29 Andreasson U,Blennow K,Zetterberg H.Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders[J].Alzheimer’s&Dementia:Diagnosis,Assessment&Disease Monitoring,2016,3(1):98-102.
30 Pallares R M,Su X,Lim S H,et al.Fine-tuning of gold nanorod dimensions and plasmonic properties using the Hofmeister effects[J].Journal of Materials Chemistry C,2016,4(1):53-61.
31 Sun J,Sun H,Liang Z.Nanomaterials in electrochemiluminescence sensors[J].Chem Electro Chem,2017,4(7):1651-1662.
32 Oh E S,Mielke M M,Rosenberg P B,et al.Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma[J].Journal of Alzheimer’s Disease,2010,21(3):769-773.
33 Chen H,Jiang C,Yu C,et al.Protein chips and nanomaterials for application in tumor marker immunoassays[J].Biosensors and Bioelectronics,2009,24(12):3399-3411.
34 Dinish U S,Beffara F,Humbert G,et al.Surface‐enhanced Raman scattering‐active photonic crystal fiber probe:Towards next generation liquid biopsy sensor with ultra high sensitivity[J].Journal of Biophotonics,2019,12(11):e201900027.
35 Gorodkiewicz E,Lukaszewski Z.Recent progress in surface plasmon resonance biosensors (2016 to Mid-2018)[J].Biosensors,2018,8(4):132.
36 Wang J,Lin W,Cao E,et al.Surface plasmon resonance sensors on Raman and fluorescence spectroscopy[J].Sensors,2017,17(12):2719.
37 Hu W,Chen H,Shi Z,et al.Dual signal amplification of surface plasmon resonance imaging for sensitive immunoassay of tumor marker[J].Analytical Biochemistry,2014,453:16-21.
38 Murphy M P,Levine I H.Alzheimer’s disease and the amyloid-β peptide[J].Journal of Alzheimer’s Disease,2010,19(1):311-323.
39 Conti S,Bonazzi S,Laiacona M,et al.Montreal cognitive assessment (Mo CA)-italian version:Regression based norms and equivalent scores[J].Neurological Sciences,2015,36(2):209-214.
40 Ercoli L M,Siddarth P,Dunkin J J,et al.MMSE items predict cognitive decline in persons with genetic risk for Alzheimer’s disease[J].Journal of geriatric psychiatry and neurology,2003,16(2):67-73.
41 Ferreira L K,Busatto G F.Neuroimaging in Alzheimer’s disease:Current role in clinical practice and potential future applications[J].Clinics,2011,66:19-24.
42 Chan H N,Xu D,Ho S L,et al.Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease[J].Chemical Science,2017,8(5):4012-4018.
43?zcan N,Medetalibeyoglu H,Aky?ld?r?m O,et al.Electrochemical detection of amyloid-β protein by delaminated titanium carbide MXene/multi-walled carbon nanotubes composite with molecularly imprinted polymer[J].Materials Today Communications,2020,23:101097.
44 Kew M.Alpha-fetoprotein in primary liver cancer and other diseases[J].Gut,1974,15(10):814-821.
45 Yang H,Zhao C,Li R,et al.Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy[J].The Analyst,2018,143(10):2235-2242.
46 Zhao L J,Yu R J,Ma W,et al.Sensitive detection of protein biomarkers using silver nanoparticles enhanced immunofluorescence assay[J].Theranostics,2017,7(4):876-883.
47 Wang C F,Wang Z G,Sun X Y,et al.An ultrasensitive fluorescent aptasensor for detection of cancer marker proteins based on graphene oxide-ss DNA[J].RSC Advances,2018,8(72):41143-41149.
48 Cha M K,Suh K H,Kim I H.Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma[J].Journal of Experimental&Clinical Cancer Research,2009,28(1):93.
49 Park B J,Cha M K,Kim I H.Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses[J].BMC Research Notes,2014,7(1):7.
50 Ebeling F G,Stieber P,Untch M,et al.Serum CEA and CA 15-3 as prognostic factors in primary breast cancer[J].British Journal of Cancer,2002,86(8):1217-1222.
51 Molina R,Jo J,Filella X,et al.C-erb B-2 oncoprotein,CEA,and CA 15.3 in patients with breast cancer:Prognostic value[J].Breast Cancer Research and Treatment,1998,51(2):109-119.
52 Lee M J,Lee E S,Kim T H,et al.Detection of thioredoxin-1 using ultra-sensitive ELISA with enzymeencapsulated human serum albumin nanoparticle[J].Nano Convergence,2019,6(1):37.
53 Hakimian F,Ghourchian H.Ultrasensitive electrochemical biosensor for detection of micro RNA-155 as a breast cancer risk factor[J].Analytica Chimica Acta,2020,1136:1-8.
54 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.
55 Todua F,Gagua R,Maglakelidze M,et al.Cancer incidence and mortality-Major patterns in GLOBOCAN 2012,worldwide and Georgia[J].Bull Georg Natl Acad Sci,2015,9(1):168-173.
56 Martini G,Troiani T,Cardone C,et al.Present and future of metastatic colorectal cancer treatment:A review of new candidate targets[J].World Journal of Gastroenterology,2017,23(26):4675.
57 Siegel R L,Miller K D,Fedewa S A,et al.Colorectal cancer statistics,2017[J].CA:A Cancer Journal for Clinicians,2017,67(3):177-193.
58 Arnold M,Sierra M S,Laversanne M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66(4):683-691.
59 Romani P,Ignesti M,Gargiulo G,et al.Extracellular NME proteins:A player or a bystander?[J].Laboratory Investigation,2018,98(2):248-257.
60 Lu Y,Liu Q,Fu B,et al.Label-free MIP-SERS biosensor for sensitive detection of colorectal cancer biomarker[J].Talanta,2023,258:124461.
61 Yao M M,Tang H,Yin Y C,et al.Tuning the surface enhanced Raman spectroscopy performance of Au core-Ag shell nanostructure for label-free highly sensitive detection of colorectal cancer marker[J].Journal of Alloys and Compounds,2022,896:163043.
62 Zhang X,Gan T,Xu Z,et al.Immune-like sandwich multiple hotspots SERS biosensor for ultrasensitive detection of NDKA biomarker in serum[J].Talanta,2024,271:125630.
63 Geurts S M E,De-Vegt F,Van-Altena A M,et al.Considering early detection of relapsed ovarian cancer:A review of the literature[J].International Journal of Gynecological Cancer,2011,21(5):837-845.
64 Zhu C S,Pinsky P F,Cramer D W,et al.A Framework for evaluating biomarkers for early detection:Validation of biomarker panels for ovarian cancer[J].Cancer Prevention Research,2011,4(3):375-383.
65 Peng N J,Liou W S,Liu R S,et al.Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography[J].Cancer Biotherapy and Radiopharmaceuticals,2011,26(2):175-181.
66 Cramer D W,Bast R C,Berg C D,et al.Ovarian cancer biomarker performance in prostate,lung,colorectal,and ovarian cancer screening trial specimens[J].Cancer Prevention Research,2011,4(3):365-374.
67 Viswanathan S,Rani C,Ribeiro S,et al.Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker[J].Biosensors and Bioelectronics,2012,33(1):179-183.
68 Viswanathan S,Rani C,Delerue-Matos C.Ultrasensitive detection of ovarian cancer marker using immunoliposomes and gold nanoelectrodes[J].Analytica Chimica Acta,2012,726:79-84.
69 Sproston N R,Ashworth J J.Role of C-reactive protein at sites of inflammation and infection[J].Frontiers in Immunology,2018,9:754.
70 Reitz C,Berger K,De-Maat M P M,et al.CRP gene haplotypes,serum CRP,and cerebral small-vessel disease:The rotterdam scan study and the MEMO study[J].Stroke,2007,38(8):2356-2359.
71 Yanbaeva D G,Dentener M A,Spruit M A,et al.IL6 and CRPhaplotypes are associated with COPD risk and systemic inflammation:A case-control study[J].BMC Medical Genetics,2009,10(1):23.
72 Zhang P,Bao Y,Draz M,et al.Rapid and quantitative detection of C-reactive protein based on quantum dots and immunofiltration assay[J].International Journal of Nanomedicine,2015:6161.
73 Biondi M,D’Alessandro P.Genus-group names of Afrotropical flea beetles (Coleoptera:Chrysomelidae:Alticinae):Annotated catalogue and biogeographical notes[J].European Journal of Entomology,2010,107(3):401-424.
74 Luo Y,Zhang B,Chen M,et al.Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay[J].Journal of Translational Medicine,2012,10(1):24.
75 Gupta P K,Son S E,Seong G H.Functionalized ultra-fine bimetallic Pt Ru alloy nanoparticle with high peroxidasemimicking activity for rapid and sensitive colorimetric quantification of C-reactive protein[J].Microchimica Acta,2021,188(4):119.
76 Hu Z,Zhou X,Duan J,et al.Aptamer-based novel Ag-coated magnetic recognition and SERS nanotags with interior nanogap biosensor for ultrasensitive detection of protein biomarker[J].Sensors and Actuators B:Chemical,2021,334:129640.
77 Ali G K,Omer K M.Ultrasensitive aptamer-functionalized Cu-MOF fluorescent nanozyme as an optical biosensor for detection of C-reactive protein[J].Analytical Biochemistry,2022,658:114928.
78 Butcher K S,Parsons M W.Cardiac enzyme elevations after stroke:The importance of specificity[J].Stroke,2002,33(8):1944-1945.
79 Katus H A,Remppis A,Neumann F J,et al.Diagnostic efficiency of troponin T measurements in acute myocardial infarction[J].Circulation,1991,83(3):902-912.
80 Munje R D,Jacobs M,Muthukumar S,et al.A novel approach for electrical tuning of nano-textured zinc oxide surfaces for ultra-sensitive troponin-T detection[J].Analytical Methods,2015,7(24):10136-10144.
81 Akanda M R,Aziz M A,Jo K,et al.Optimization of phosphatase-and redox cycling-based immunosensors and Its application to ultrasensitive detection of troponin I[J].Analytical Chemistry,2011,83(10):3926-3933.
82 Diware M S,Cho H M,Chegal W,et al.Ultrasensitive,label-free detection of cardiac biomarkers with optical SISsensor[J].Biosensors and Bioelectronics,2017,87:242-248.
基本信息:
DOI：10.16026/j.cnki.iea.2025010046
中图分类号:TP212.3;R446.1
引用信息:
[1]王海涛 ,马晓媛 ,宋艳冰 等.蛋白质生物标志物超灵敏检测技术的研究进展[J].离子交换与吸附,2025,41(01):46-63.DOI:10.16026/j.cnki.iea.2025010046.
基金信息:
国家自然科学基金重点项目(基金号52033004); 天津工业大学沧州研究院第二批孵化与产业化项目(基金号TGCYY-F-0203); 河北省自然科学基金面上项目(基金号E2023110007); 沧州市重点研发计划指导项目(基金号222107007)